0

Journal Articles

in Hepatobiliary Cancer
 1-16 of 16 Articles
Preliminary Communication |  November 14, 2012 FREE
Association Between Nucleoside Analogues and Risk of Hepatitis B Virus–Related Hepatocellular Carcinoma Recurrence Following Liver Resection
Chun-Ying Wu, MD, PhD, MPH; Yi-Ju Chen, MD, PhD; Hsiu J. Ho, PhD; et al.
JAMA. 2012;308(18):1906-1913. doi:10.1001/2012.jama.11975.
INCLUDES: , Supplemental Content
Editorial |  November 14, 2012
Does Antiviral Therapy Prevent Recurrence of Hepatitis B Virus–Related Hepatocellular Carcinoma After Curative Liver Resection?
Anna S. F. Lok, MD
JAMA. 2012;308(18):1922-1924. doi:10.1001/jama.2012.12971.
Preliminary Communication |  November 17, 2010 FREE
Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma:  A Randomized Trial
Ghassan K. Abou-Alfa, MD; Philip Johnson, MD; Jennifer J. Knox, MD; et al.
JAMA. 2010;304(19):2154-2160. doi:10.1001/jama.2010.1672.
INCLUDES: , Supplemental Content
The World in Medicine |  June 16, 2010
Men and Liver Cancer
Joan Stephenson, PhD
JAMA. 2010;303(23):2346. doi:10.1001/jama.2010.797.
From the Centers for Disease Control and Prevention |  June 16, 2010 FREE
Hepatocellular Carcinoma—United States, 2001-2006
JAMA. 2010;303(23):2349-2350. doi:.
Original Contribution |  March 17, 2010 FREE
Imaging Response in the Primary Index Lesion and Clinical Outcomes Following Transarterial Locoregional Therapy for Hepatocellular Carcinoma
Ahsun Riaz, MD; Frank H. Miller, MD; Laura M. Kulik, MD; et al.
JAMA. 2010;303(11):1062-1069. doi:10.1001/jama.2010.262.
INCLUDES: , Supplemental Content
Preliminary Communication |  December 02, 2009 FREE
Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases
Yun Shin Chun, MD; Jean-Nicolas Vauthey, MD; Piyaporn Boonsirikamchai, MD; et al.
JAMA. 2009;302(21):2338-2344. doi:10.1001/jama.2009.1755.
The World in Medicine |  November 18, 2009
MicroRNA and Liver Cancer
Joan Stephenson, PhD
JAMA. 2009;302(19):2083. doi:10.1001/jama.2009.1682.
Editorial |  May 13, 2009
Retraction: Cheng B-Q, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA. 2008;299(14):1669-1677.
Catherine D. DeAngelis, MD, MPH; Phil B. Fontanarosa, MD, MBA
JAMA. 2009;301(18):1931. doi:10.1001/jama.2009.640.
Editorial |  April 09, 2008
Expanding the Treatment Options for Hepatocellular Carcinoma:  Combining Transarterial Chemoembolization With Radiofrequency Ablation
Andrew X. Zhu, MD, PhD; Ghassan K. Abou-Alfa, MD
JAMA. 2008;299(14):1716-1718. doi:10.1001/jama.299.14.1716.
Original Contribution |  April 09, 2008 FREE
Chemoembolization Combined With Radiofrequency Ablation for Patients With Hepatocellular Carcinoma Larger Than 3 cm:  A Randomized Controlled Trial
Bao-Quan Cheng, MD, PhD; Chong-Qi Jia, PhD; Chun-Tao Liu, MD; et al.
JAMA. 2008;299(14):1669-1677. doi:10.1001/jama.299.14.1669.
Original Contribution |  January 02, 2008 FREE
Epidermal Growth Factor Gene Functional Polymorphism and the Risk of Hepatocellular Carcinoma in Patients With Cirrhosis
Kenneth K. Tanabe, MD; Antoinette Lemoine, PharmD, PhD; Dianne M. Finkelstein, PhD; et al.
JAMA. 2008;299(1):53-60. doi:10.1001/jama.2007.65.
Original Contribution |  January 04, 2006 FREE
Risk of Hepatocellular Carcinoma Across a Biological Gradient of Serum Hepatitis B Virus DNA Level
Chien-Jen Chen, ScD; Hwai-I. Yang, MSc; Jun Su, MD, MSc; et al.
JAMA. 2006;295(1):65-73. doi:10.1001/jama.295.1.65.
Preliminary Communication |  July 21, 2004 FREE
Role of Vitamin K2 in the Development of Hepatocellular Carcinoma in Women With Viral Cirrhosis of the Liver
Daiki Habu, MD, PhD; Susumu Shiomi, MD, PhD; Akihiro Tamori, MD, PhD; et al.
JAMA. 2004;292(3):358-361. doi:10.1001/jama.292.3.358.
From the Food and Drug Administration |  May 01, 2002
Treatment for Liver Tumors
JAMA. 2002;287(17):2203. doi:10.1001/jama.287.17.2203.
Brief Report |  December 20, 2000 FREE
Hepatitis B Vaccination and Hepatocellular Carcinoma Rates in Boys and Girls
Mei-Hwei Chang, MD; Wen-Yi Shau, MD, PhD; Chien-Jen Chen, ScD; et al.
JAMA. 2000;284(23):3040-3042. doi:10.1001/jama.284.23.3040.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  May 8, 2013
Long-term Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases
Paul J. Karanicolas, MD, PhD; William R. Jarnagin, MD; Mithat Gonen, PhD; et al.
JAMA Surgery
Invited Critique  |  May 8, 2013
To Ablate or Not to Ablate?: That Is the Question:  Comment on “Tumor Ablation Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases”
Karen L. Sherman, MD; David J. Bentrem, MD, MS
JAMA Ophthalmology
Clinical Sciences  |  February 7, 2013
Progression of Ocular Melanoma Metastasis to the Liver:  The 2012 Zimmerman Lecture
Hans E. Grossniklaus, MD
JAMA Surgery
Invited Critique  |  April 01, 2013
Treatment Sequence for Colorectal Cancer With Hepatic Metastases:  Comment on “The Liver-First Approach to the Management of Colorectal Cancer With Synchronous Hepatic Metastases”
Andrew Klein, MD, MBA
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems